Memory-based strategies for antiretroviral medication management: An evaluation of clinical predictors, adherence behavior awareness, and effectiveness

AIDS and Behavior

Volumn 17, Issue 1, 2013, Pages 74-85

  Blackstone, K ^a   Woods, S P ^b   Weber, E ^a   Grant, I ^b   Moore, D J ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Infectious disease; Medications; Mnemonic devices; Self awareness

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; AWARENESS; DAILY LIFE ACTIVITY; EVALUATION; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PREDICTIVE VALUE; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; REMINDER SYSTEM; RISK FACTOR; SELF REPORT; SOCIOECONOMICS; STATISTICS;

ACTIVITIES OF DAILY LIVING; ADULT; ANTI-HIV AGENTS; AWARENESS; FEMALE; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; REMINDER SYSTEMS; RISK FACTORS; SELF REPORT; SOCIOECONOMIC FACTORS;

MLCS; MLOWN;

EID: 84872684561     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0308-9     Document Type: Article

References (43)

1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-66.
2. Bartlett JG. International HIV workshop on management of treatment-experienced patients. Hopkins HIV Rep. 2002;14(6):4-5.
3. Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33(8):1417-23.
4. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(5):435-42.
5. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119(6):e1371-83.
6. Vyavaharkar M, Moneyham L, Tavakoli A, Phillips KD, Murdaugh C, Jackson K, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDS. 2007;21(9):667-80.
7. Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731-47.
8. Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008;22(3):233-43.
9. Beusterien KM, Davis EA, Flood R, Howard K, Jordan J. HIV patient insight on adhering to medication: a qualitative analysis. AIDS Care. 2008;20(2):244-52.
10. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944-50.
11. Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009;15(1):42-52.
12. Kalichman SC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDS. 2005;19(12):833-9.
13. Miller W, Hecht FM. Adherence to HIV treatment. Clinical Care of AIDS Patients 1997.
14. Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110-7.
15. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386-95.
16. Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15(6):787-93.
17. Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, Rybin D, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011;25(3):153-61.
18. Andrade AS, McGruder HF, Wu AW, Celano SA, Skolasky RL Jr, Selnes OA, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41(6):875-82.
19. Safren SA, Otto MW, Worth JL, Salomon E, Johnson W, Mayer K, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151-62.
20. Kalichman SC, Rompa D, DiFonzo K, Simpson D, Austin J, Luke W, et al. HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills model of health behavior. J Assoc Nurses AIDS Care. 2001;12(4):58-67.
21. Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908-15.
22. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40-9.
23. Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). J Behav Med. 2007;30(5):359-70.
24. Gould ON, McDonald-Miszczak L, King B. Metacognition and medication adherence: how do older adults remember? Exp Aging Res. 1997;23(4):315-42.
25. Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology. 2003;17(3):410-9.
26. Moore LH, van Gorp WG, Hinkin CH, Stern MJ, Swales T, Satz P. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals. J Neuropsychiatry Clin Neurosci. 1997;9(1):37-44.
27. Woods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 2007;22(2):187-95.
28. Hinkin CH, van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18(3):431-43.
29. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86-94.
30. Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007;63(12):1115-21.
31. McNair A, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego: Educational and Industrial Testing Services; 1981.
32. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the composite international diagnostic interview (CIDI). The multicentre WHO/ADAMHA field trials. Br J Psychiatry. 1991;159:645-653, 658.
33. First MB, Spitzer RL, Gibbon M, WIlliams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. Institute NYSP, editor. New York: Biometrics Research; 1991.
34. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tuscon: Neuropsychology Press; 1985.
35. Kløve H. Grooved pegboard. Lafayette: Lafayette Instruments; 1963.
36. Woods SP, Carey CL, Troster AI, Grant I. Action (verb) generation in HIV-1 infection. Neuropsychologia. 2005;43(8):1144-51.
37. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317-31.
38. Heaton RK, Taylor MJ, Manly J, Tulsky DS. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. Clinical interpretation of the WAIS-III and WMS-III. Burlington: Academic; 2003. p. 181-210.
39. Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, et al. Demographically corrected norms for African Americans and Caucasians on the hopkins verbal learning test-revised, brief visuospatial memory test-revised, stroop color and word test, and Wisconsin card sorting test 64-card version. J Clin Exp Neuropsychol. 2011;33(7):793-804.
40. Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(3):273-8.
41. Woods SP, Moran LM, Carey CL, Dawson, Iudicello JE, Gibson S, et al. Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23(3):257-70.
42. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136-42.
43. Juengst S, Skidmore E, Pramuka M, McCue M, Becker J. Factors contributing to impaired self-awareness of cognitive functioning in an HIV positive and at-risk population. Disabil Rehabil. 2012;34(1):19-25.